inSoma Bio

Durham, NC · Founded 2018 · Privately Held (backing)

Developer of bioengineered reconstructive biomaterials designed to enable the use of a person's tissue in surgical procedures. inSoma Bio is based in Durham, NC and was founded in 2018. Its last reported valuation was $18.7 million in May 2024. It has raised $7.8 million across 3 recorded rounds; the latest was a $2.7 million seed round in Sep 2025.

Last reported valuation
$18.7M
Oct 2026
Priced at
—
Total raised
$7.8M
Last round
Seed Round
Sep 2025

Who backs inSoma Bio?

23 investors
InvestorType
Y CombinatorOther
US National Science FoundationOther
MedTech InnovatorOther
National Institutes of HealthOther
Makai VCVenture capital
Asymmetry VenturesVenture capital
Duke Capital PartnersVenture capital
FemHealth VenturesVenture capital
Deep Ventures (Venture Capital)Venture capital
Wallace H. Coulter FoundationOther
+ 13 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

inSoma Bio investors

23 investors are on record for inSoma Bio, including Y Combinator, US National Science Foundation, MedTech Innovator and National Institutes of Health. By type, the record holds 5 venture capital firms and 1 family office. The seed round in Sep 2025 drew 15 investors.

Free account
More of inSoma Bio with a free account
  • ·The complete investor list: 23 names
  • ·Watch inSoma Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 23 firms already write checks for companies like inSoma Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View